Related Experiment Videos
Gene therapy for gastrointestinal tract cancer: a review
D A Heideman1, W R Gerritsen, M E Craanen
1Dept. of Gastroenterology, University Hospital Vrije Universiteit, P. O. Box 7057, 1081 HV Amsterdam, The Netherlands.
Abstract:
Carcinomas of the gastrointestinal tract count as one of the most common causes of cancer-related death in the world. Despite improvement of conventional treatment modalities, the prognosis of patients with gastrointestinal tract cancer remains poor. Progress in understanding the molecular mechanism of gastrointestinal carcinogenesis may facilitate development of gene therapy strategies for the treatment of gastrointestinal tumors. This review describes new developments in vectors (tools for gene transfer) for gene therapy, possible therapeutic genes and the early clinical results of gastrointestinal tract cancer gene therapy. Results of current preclinical studies are promising for the future clinical application of gene therapy for gastrointestinal cancer. The first clinical trials have been initiated recently, the preliminary results reflecting low toxicity and clinical responses. Further clinical studies will be required to confirm the feasibility of gene therapy in the treatment of gastrointestinal cancer. In future, the greatest potential will probably lie in the field of combination strategies of gene therapy and existing treatment modalities, such as surgery combined with molecular chemotherapy.
Insights
Gene therapy offers a promising new avenue for treating gastrointestinal cancer, with early clinical trials showing low toxicity and positive responses. Further research is needed to confirm its effectiveness, potentially in combination with existing treatments.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Gastrointestinal tract carcinomas are a leading cause of cancer mortality globally.
- Conventional treatments for gastrointestinal cancer have limited efficacy, leading to poor patient prognoses.
- Understanding the molecular basis of gastrointestinal carcinogenesis is crucial for developing novel therapies.
Purpose of the Study:
- To review advancements in gene therapy for gastrointestinal cancer.
- To discuss novel gene transfer vectors and therapeutic genes.
- To summarize early clinical outcomes of gastrointestinal cancer gene therapy.
Main Methods:
- Review of preclinical studies and early clinical trials on gene therapy for gastrointestinal cancer.
- Analysis of gene transfer vectors and potential therapeutic genes.
- Evaluation of reported toxicity and clinical responses.
Main Results:
- Preclinical studies demonstrate promising results for gene therapy in gastrointestinal cancer.
- Initial clinical trials report low toxicity and observable clinical responses.
- Emerging data suggests feasibility for future clinical application.
Conclusions:
- Gene therapy holds significant potential for treating gastrointestinal tumors.
- Further clinical studies are essential to validate gene therapy's efficacy.
- Combination strategies, integrating gene therapy with conventional treatments like surgery and chemotherapy, may offer the greatest future potential.